{"actionType":"INHIBITOR","mechanismOfAction":"Phosphodiesterase 3A inhibitor","chemblIds":["CHEMBL1752"],"targetName":"Phosphodiesterase 3A","targetType":"single protein","targets":["ENSG00000172572"],"references":[{"source":"DailyMed","ids":["archiveid=55650","archiveid=55650"],"urls":["http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=55650","http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=55650"]},{"source":"PubMed","ids":["21683458","21683458"],"urls":["http://europepmc.org/abstract/MED/21683458","http://europepmc.org/abstract/MED/21683458"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"B-lymphocyte antigen CD20 binding agent","chemblIds":["CHEMBL2109348"],"targetName":"B-lymphocyte antigen CD20","targetType":"single protein","targets":["ENSG00000156738"],"references":[{"source":"PubMed","ids":["21455568"],"urls":["http://europepmc.org/abstract/MED/21455568"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Epidermal growth factor receptor inhibitor","chemblIds":["CHEMBL4297774"],"targetName":"Epidermal growth factor receptor erbB1","targetType":"single protein","targets":["ENSG00000146648"],"references":[{"source":"PubMed","ids":["32414908","32414908"],"urls":["https://pubmed.ncbi.nlm.nih.gov/32414908/","https://pubmed.ncbi.nlm.nih.gov/32414908/"]}]}
{"mechanismOfAction":"Osmotic laxative","chemblIds":["CHEMBL1201479"],"references":[{"source":"BNF","ids":["https://bnf.nice.org.uk/drug/macrogol-3350.html"],"urls":["https://bnf.nice.org.uk/drug/macrogol-3350.html"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Fusion glycoprotein F0 inhibitor","chemblIds":["CHEMBL3707327"],"targetName":"Fusion glycoprotein F0","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["27960628"],"urls":["http://europepmc.org/abstract/MED/27960628"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Egl nine homolog 1 inhibitor","chemblIds":["CHEMBL3646118"],"targetName":"Egl nine homolog 1","targetType":"single protein","targets":["ENSG00000135766"],"references":[{"source":"PubMed","ids":["25392999","25392999","25392999"],"urls":["https://pubmed.ncbi.nlm.nih.gov/25392999/","https://pubmed.ncbi.nlm.nih.gov/25392999/","https://pubmed.ncbi.nlm.nih.gov/25392999/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL1200751","CHEMBL1425"],"references":[{"source":"DailyMed","ids":["setid=15904472-4c32-4224-95d3-eb131a7ff9c8","setid=15904472-4c32-4224-95d3-eb131a7ff9c8"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15904472-4c32-4224-95d3-eb131a7ff9c8","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15904472-4c32-4224-95d3-eb131a7ff9c8"]},{"source":"PubMed","ids":["18506437","18506437"],"urls":["http://europepmc.org/abstract/MED/18506437","http://europepmc.org/abstract/MED/18506437"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Glucocorticoid receptor agonist","chemblIds":["CHEMBL1676"],"targetName":"Glucocorticoid receptor","targetType":"single protein","targets":["ENSG00000113580"],"references":[{"source":"DailyMed","ids":["setid=4eeb5f6a-593f-4a9e-9692-adefa2caf8fc"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4eeb5f6a-593f-4a9e-9692-adefa2caf8fc"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Programmed cell death protein 1 inhibitor","chemblIds":["CHEMBL4297858"],"targetName":"Programmed cell death protein 1","targetType":"single protein","targets":["ENSG00000188389"],"references":[{"source":"PubMed","ids":["34216247"],"urls":["https://pubmed.ncbi.nlm.nih.gov/34216247/"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"Sucrose hydrolytic enzyme","chemblIds":["CHEMBL1201487"],"references":[{"source":"DailyMed","ids":["setid=d613bb7f-c3f4-462e-81a2-da2347cc4b6b"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d613bb7f-c3f4-462e-81a2-da2347cc4b6b"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Cholecystokinin A receptor antagonist","chemblIds":["CHEMBL550781"],"targetName":"Cholecystokinin A receptor","targetType":"single protein","targets":["ENSG00000163394"],"references":[{"source":"PubMed","ids":["15743365"],"urls":["http://europepmc.org/abstract/MED/15743365"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Opioid receptors; mu/kappa/delta agonist","chemblIds":["CHEMBL3833389"],"targetName":"Opioid receptors; mu/kappa/delta","targetType":"protein family","targets":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"references":[{"source":"PubMed","ids":["10574310","15268688"],"urls":["http://europepmc.org/abstract/MED/10574310","http://europepmc.org/abstract/MED/15268688"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Synaptic vesicular amine transporter inhibitor","chemblIds":["CHEMBL772"],"targetName":"Synaptic vesicular amine transporter","targetType":"single protein","targets":["ENSG00000165646"],"references":[{"source":"DailyMed","ids":["setid=3a4d74d7-2e63-4789-b50e-af17ced92462"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a4d74d7-2e63-4789-b50e-af17ced92462"]},{"source":"ISBN","ids":["9780702034718 PP. 177"],"urls":["http://www.isbnsearch.org/isbn/9780702034718"]},{"source":"Wikipedia","ids":["Reserpine","Vesicular_monoamine_transporter_1"],"urls":["http://en.wikipedia.org/wiki/Reserpine","http://en.wikipedia.org/wiki/Vesicular_monoamine_transporter_1"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Beta-2 adrenergic receptor antagonist","chemblIds":["CHEMBL1201177","CHEMBL1201237"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"DailyMed","ids":["setid=1a32c0e8-7d10-447e-a7c4-252c98b629bd","setid=1a32c0e8-7d10-447e-a7c4-252c98b629bd"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a32c0e8-7d10-447e-a7c4-252c98b629bd","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a32c0e8-7d10-447e-a7c4-252c98b629bd"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Macrophage colony stimulating factor receptor inhibitor","chemblIds":["CHEMBL2109322"],"targetName":"Macrophage colony stimulating factor receptor","targetType":"single protein","targets":["ENSG00000182578"],"references":[{"source":"PubMed","ids":["28655795"],"urls":["http://europepmc.org/abstract/MED/28655795"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Peroxisome proliferator-activated receptor alpha agonist","chemblIds":["CHEMBL282686"],"targetName":"Peroxisome proliferator-activated receptor alpha","targetType":"single protein","targets":["ENSG00000186951"],"references":[{"source":"PubMed","ids":["15059948","16628256","15059948","16628256"],"urls":["http://europepmc.org/abstract/MED/15059948","http://europepmc.org/abstract/MED/16628256","http://europepmc.org/abstract/MED/15059948","http://europepmc.org/abstract/MED/16628256"]},{"source":"Wikipedia","ids":["Tesaglitazar","Tesaglitazar"],"urls":["http://en.wikipedia.org/wiki/Tesaglitazar","http://en.wikipedia.org/wiki/Tesaglitazar"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine 3-hydroxylase inhibitor","chemblIds":["CHEMBL1200862"],"targetName":"Tyrosine 3-hydroxylase","targetType":"single protein","targets":["ENSG00000180176"],"references":[{"source":"DailyMed","ids":["setid=32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor receptor 3 inhibitor","chemblIds":["CHEMBL2109602"],"targetName":"Vascular endothelial growth factor receptor 3","targetType":"single protein","targets":["ENSG00000037280"],"references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=695064"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=695064"]},{"source":"PubMed","ids":["27566701"],"urls":["http://europepmc.org/abstract/MED/27566701"]}]}
{"actionType":"POSITIVE ALLOSTERIC MODULATOR","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","chemblIds":["CHEMBL70418"],"targetName":"GABA-A receptor; anion channel","targetType":"protein complex group","targets":["ENSG00000022355","ENSG00000145864","ENSG00000113327","ENSG00000166206","ENSG00000109158","ENSG00000182256","ENSG00000268089","ENSG00000011677","ENSG00000094755","ENSG00000187730","ENSG00000163285","ENSG00000163288","ENSG00000102287","ENSG00000151834","ENSG00000186297","ENSG00000145863"],"references":[{"source":"Wikipedia","ids":["Clobazam"],"urls":["http://en.wikipedia.org/wiki/Clobazam"]},{"source":"PubMed","ids":["11530681"],"urls":["http://europepmc.org/abstract/MED/11530681"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","chemblIds":["CHEMBL3039525"],"targetName":"Vascular endothelial growth factor receptor 2","targetType":"single protein","targets":["ENSG00000128052"],"references":[{"source":"PubMed","ids":["19832844","25110867","19832844","25110867"],"urls":["http://europepmc.org/abstract/MED/19832844","http://europepmc.org/abstract/MED/25110867","http://europepmc.org/abstract/MED/19832844","http://europepmc.org/abstract/MED/25110867"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Kelch-like ECH-associated protein 1 inhibitor","chemblIds":["CHEMBL589586"],"targetName":"Kelch-like ECH-associated protein 1","targetType":"single protein","targets":["ENSG00000079999"],"references":[{"source":"FDA","ids":["label/2020/210296s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210296s000lbl.pdf"]},{"source":"PubMed","ids":["27277809","30820593"],"urls":["http://europepmc.org/abstract/MED/27277809","http://europepmc.org/abstract/MED/30820593"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Serotonin 2c (5-HT2c) receptor antagonist","chemblIds":["CHEMBL654"],"targetName":"Serotonin 2c (5-HT2c) receptor","targetType":"single protein","targets":["ENSG00000147246"],"references":[{"source":"DailyMed","ids":["setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1","setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1","setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Plasma kallikrein inhibitor","chemblIds":["CHEMBL1201619"],"targetName":"Plasma kallikrein","targetType":"single protein","targets":["ENSG00000164344"],"references":[{"source":"DailyMed","ids":["setid=8a5982c6-825f-4d05-90f5-1519a7291d15#nlm34090-1","setid=8a5982c6-825f-4d05-90f5-1519a7291d15#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a5982c6-825f-4d05-90f5-1519a7291d15#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a5982c6-825f-4d05-90f5-1519a7291d15#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Angiotensin-converting enzyme inhibitor","chemblIds":["CHEMBL1560"],"targetName":"Angiotensin-converting enzyme","targetType":"single protein","targets":["ENSG00000159640"],"references":[{"source":"FDA","ids":["label/2015/018343s086lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018343s086lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Fibroblast growth factor receptor 3 inhibitor","chemblIds":["CHEMBL522892"],"targetName":"Fibroblast growth factor receptor 3","targetType":"single protein","targets":["ENSG00000068078"],"references":[{"source":"PubMed","ids":["15897558","15897558","15897558","15897558","15897558"],"urls":["http://europepmc.org/abstract/MED/15897558","http://europepmc.org/abstract/MED/15897558","http://europepmc.org/abstract/MED/15897558","http://europepmc.org/abstract/MED/15897558","http://europepmc.org/abstract/MED/15897558"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL2109648"],"references":[]}
{"actionType":"AGONIST","mechanismOfAction":"Melanocortin receptor 4 agonist","chemblIds":["CHEMBL4297533","CHEMBL2070241"],"targetName":"Melanocortin receptor 4","targetType":"single protein","targets":["ENSG00000166603"],"references":[{"source":"PubMed","ids":["12851303","17584130"],"urls":["http://europepmc.org/abstract/MED/12851303","http://europepmc.org/abstract/MED/17584130"]},{"source":"Wikipedia","ids":["Bremelanotide"],"urls":["http://en.wikipedia.org/wiki/Bremelanotide"]},{"source":"FDA","ids":["label/2019/210557s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL43128","CHEMBL506"],"references":[{"source":"PubMed","ids":["20713019"],"urls":["http://europepmc.org/abstract/MED/20713019"]},{"source":"Wikipedia","ids":["Hemozoin","Primaquine"],"urls":["http://en.wikipedia.org/wiki/Hemozoin","http://en.wikipedia.org/wiki/Primaquine"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"c-Jun N-terminal kinase, JNK inhibitor","chemblIds":["CHEMBL3545213"],"targetName":"c-Jun N-terminal kinase, JNK","targetType":"protein family","targets":["ENSG00000107643","ENSG00000109339","ENSG00000050748"],"references":[{"source":"PubMed","ids":["20855355"],"urls":["http://europepmc.org/abstract/MED/20855355"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Glutamate [NMDA] receptor antagonist","chemblIds":["CHEMBL1569","CHEMBL660"],"targetName":"Glutamate [NMDA] receptor","targetType":"protein complex group","targets":["ENSG00000176884","ENSG00000183454","ENSG00000273079","ENSG00000105464","ENSG00000116032","ENSG00000161509","ENSG00000198785"],"references":[{"source":"DailyMed","ids":["setid=a2caed21-e9a3-228e-70a8-de30a1b368be","setid=a2caed21-e9a3-228e-70a8-de30a1b368be"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2caed21-e9a3-228e-70a8-de30a1b368be","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2caed21-e9a3-228e-70a8-de30a1b368be"]},{"source":"Wikipedia","ids":["Amantadine#Dosage_and_mechanism_of_action","Amantadine#Dosage_and_mechanism_of_action"],"urls":["http://en.wikipedia.org/wiki/Amantadine#Dosage_and_mechanism_of_action","http://en.wikipedia.org/wiki/Amantadine#Dosage_and_mechanism_of_action"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase BTK inhibitor","chemblIds":["CHEMBL4072833"],"targetName":"Tyrosine-protein kinase BTK","targetType":"single protein","targets":["ENSG00000010671"],"references":[{"source":"PubMed","ids":["30988116","31368705"],"urls":["http://europepmc.org/abstract/MED/30988116","http://europepmc.org/abstract/MED/31368705"]},{"source":"Other","ids":["https://www.merckgroup.com/investors/events-and-presentations/webcasts-and-presentations/2020/en/2020_Evobrutinib_Strategy_Update_EN.pdf"],"urls":["https://www.merckgroup.com/investors/events-and-presentations/webcasts-and-presentations/2020/en/2020_Evobrutinib_Strategy_Update_EN.pdf"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Tumor necrosis factor receptor superfamily member 8 binding agent","chemblIds":["CHEMBL2109255"],"targetName":"Tumor necrosis factor receptor superfamily member 8","targetType":"single protein","targets":["ENSG00000120949"],"references":[{"source":"PubMed","ids":["17488826"],"urls":["http://europepmc.org/abstract/MED/17488826"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H3 receptor antagonist","chemblIds":["CHEMBL1829335"],"targetName":"Histamine H3 receptor","targetType":"single protein","targets":["ENSG00000101180"],"references":[{"source":"PubMed","ids":["21634396","22001260"],"urls":["http://europepmc.org/abstract/MED/21634396","http://europepmc.org/abstract/MED/22001260"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase mTOR inhibitor","chemblIds":["CHEMBL1234354"],"targetName":"Serine/threonine-protein kinase mTOR","targetType":"single protein","targets":["ENSG00000198793"],"references":[{"source":"PubMed","ids":["15705718","21750219","15705718","21750219"],"urls":["http://europepmc.org/abstract/MED/15705718","http://europepmc.org/abstract/MED/21750219","http://europepmc.org/abstract/MED/15705718","http://europepmc.org/abstract/MED/21750219"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Trophoblast glycoprotein binding agent","chemblIds":["CHEMBL4297804"],"targetName":"Trophoblast glycoprotein","targetType":"single protein","targets":["ENSG00000146242"],"references":[{"source":"PubMed","ids":["28070718","28070718"],"urls":["http://europepmc.org/abstract/MED/28070718","http://europepmc.org/abstract/MED/28070718"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase B-raf inhibitor","chemblIds":["CHEMBL3545005"],"targetName":"Serine/threonine-protein kinase B-raf","targetType":"single protein","targets":["ENSG00000157764"],"references":[{"source":"PubMed","ids":["24422853","26466569"],"urls":["http://europepmc.org/abstract/MED/24422853","http://europepmc.org/abstract/MED/26466569"]},{"source":"Other","ids":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=756043"],"urls":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=756043"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tumor necrosis factor receptor superfamily member 5 inhibitor","chemblIds":["CHEMBL4298210"],"targetName":"Tumor necrosis factor receptor superfamily member 5","targetType":"single protein","targets":["ENSG00000101017"],"references":[{"source":"PubMed","ids":["29665205"],"urls":["http://europepmc.org/abstract/MED/29665205"]},{"source":"Other","ids":["https://www.novartis.com/news/media-releases/novartis-presents-first-its-kind-histology-data-iscalimab-cfz533-suggesting-extended-survival-transplanted-organs-may-be-possible"],"urls":["https://www.novartis.com/news/media-releases/novartis-presents-first-its-kind-histology-data-iscalimab-cfz533-suggesting-extended-survival-transplanted-organs-may-be-possible"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase BTK inhibitor","chemblIds":["CHEMBL3301600","CHEMBL3301625"],"targetName":"Tyrosine-protein kinase BTK","targetType":"single protein","targets":["ENSG00000010671"],"references":[{"source":"PubMed","ids":["23709115"],"urls":["http://europepmc.org/abstract/MED/23709115"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Serotonin 2a (5-HT2a) receptor antagonist","chemblIds":["CHEMBL3188993","CHEMBL716"],"targetName":"Serotonin 2a (5-HT2a) receptor","targetType":"single protein","targets":["ENSG00000102468"],"references":[{"source":"DailyMed","ids":["setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1","setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1","setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"CAMPATH-1 antigen inhibitor","chemblIds":["CHEMBL1201587"],"targetName":"CAMPATH-1 antigen","targetType":"single protein","targets":["ENSG00000169442"],"references":[{"source":"DailyMed","ids":["setid=4f5f7255-7abc-4328-bd1a-ceaf139ef3e0"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f5f7255-7abc-4328-bd1a-ceaf139ef3e0"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatitis C virus serine protease, NS3/NS4A inhibitor","chemblIds":["CHEMBL2105750"],"targetName":"Hepatitis C virus serine protease, NS3/NS4A","targetType":"protein complex","targets":[],"references":[{"source":"ClinicalTrials","ids":["NCT01849562"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT01849562"]},{"source":"Other","ids":["http://ir.achillion.com/news-releases/news-release-details/achillion-announces-first-human-dosing-ach-1625-treatment"],"urls":["http://ir.achillion.com/news-releases/news-release-details/achillion-announces-first-human-dosing-ach-1625-treatment"]},{"source":"PubMed","ids":["24735613"],"urls":["http://europepmc.org/abstract/MED/24735613"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Endothelial PAS domain-containing protein 1 inhibitor","chemblIds":["CHEMBL4585668"],"targetName":"Endothelial PAS domain-containing protein 1","targetType":"single protein","targets":["ENSG00000116016"],"references":[{"source":"ClinicalTrials","ids":["NCT04586231"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT04586231"]},{"source":"Other","ids":["https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.6_suppl.273","https://bit.ly/3cMuNwn"],"urls":["https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.6_suppl.273","https://bit.ly/3cMuNwn"]}]}
{"actionType":"POSITIVE ALLOSTERIC MODULATOR","mechanismOfAction":"Muscarinic acetylcholine receptor M1 positive allosteric modulator","chemblIds":["CHEMBL4594351"],"targetName":"Muscarinic acetylcholine receptor M1","targetType":"single protein","targets":["ENSG00000168539"],"references":[{"source":"PubMed","ids":["29581537","30089885","30856192"],"urls":["http://europepmc.org/abstract/MED/29581537","http://europepmc.org/abstract/MED/30089885","http://europepmc.org/abstract/MED/30856192"]}]}
{"mechanismOfAction":"Skin preparation/antiseptic, oxidising agent","chemblIds":["CHEMBL1201721"],"references":[{"source":"PubMed","ids":["32571829"],"urls":["http://europepmc.org/abstract/MED/32571829"]},{"source":"DailyMed","ids":["setid=22a10a54-6a04-48b3-9ec4-b26526183daf"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22a10a54-6a04-48b3-9ec4-b26526183daf"]}]}
{"mechanismOfAction":"Osmotic laxative","chemblIds":["CHEMBL3989480"],"references":[{"source":"DailyMed","ids":["setid=b7ff0059-83e7-4432-b3df-9bbeb8b3754f"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7ff0059-83e7-4432-b3df-9bbeb8b3754f"]},{"source":"HMA","ids":["https://mri.cts-mrp.eu/Human/Downloads/AT_H_0470_001_FinalSPC.pdf"],"urls":["https://mri.cts-mrp.eu/Human/Downloads/AT_H_0470_001_FinalSPC.pdf"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Sodium channel protein type X alpha subunit blocker","chemblIds":["CHEMBL3545165"],"targetName":"Sodium channel protein type X alpha subunit","targetType":"single protein","targets":["ENSG00000185313"],"references":[{"source":"Other","ids":["http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf","http://www.jurology.com/article/S0022-5347(08)60371-7/pdf","http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf","http://www.jurology.com/article/S0022-5347(08)60371-7/pdf","http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf","http://www.jurology.com/article/S0022-5347(08)60371-7/pdf"],"urls":["http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf","http://www.jurology.com/article/S0022-5347(08)60371-7/pdf","http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf","http://www.jurology.com/article/S0022-5347(08)60371-7/pdf","http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf","http://www.jurology.com/article/S0022-5347(08)60371-7/pdf"]},{"source":"PubMed","ids":["21206614","21206614"],"urls":["http://europepmc.org/abstract/MED/21206614","http://europepmc.org/abstract/MED/21206614"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Beta-2 adrenergic receptor agonist","chemblIds":["CHEMBL3545087"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[]}
{"mechanismOfAction":"Probiotic","chemblIds":["CHEMBL2109070"],"references":[{"source":"DailyMed","ids":["setid=afa81aad-6ada-4275-9946-e9fceb62bfe9","setid=cfe35d19-52f9-41b7-9997-34bf95c1a898"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=afa81aad-6ada-4275-9946-e9fceb62bfe9","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfe35d19-52f9-41b7-9997-34bf95c1a898"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Somatostatin receptor 5 agonist","chemblIds":["CHEMBL3545188","CHEMBL3039583"],"targetName":"Somatostatin receptor 5","targetType":"single protein","targets":["ENSG00000162009"],"references":[{"source":"DailyMed","ids":["setid=5504116c-d531-4d47-b160-41c6671d52aa","setid=5504116c-d531-4d47-b160-41c6671d52aa","setid=5504116c-d531-4d47-b160-41c6671d52aa","setid=5504116c-d531-4d47-b160-41c6671d52aa"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa"]},{"source":"PubMed","ids":["11980628","22397653","11980628","22397653","11980628","22397653","11980628","22397653"],"urls":["http://europepmc.org/abstract/MED/11980628","http://europepmc.org/abstract/MED/22397653","http://europepmc.org/abstract/MED/11980628","http://europepmc.org/abstract/MED/22397653","http://europepmc.org/abstract/MED/11980628","http://europepmc.org/abstract/MED/22397653","http://europepmc.org/abstract/MED/11980628","http://europepmc.org/abstract/MED/22397653"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Phosphodiesterase 4 inhibitor","chemblIds":["CHEMBL4297287"],"targetName":"Phosphodiesterase 4","targetType":"protein family","targets":["ENSG00000065989","ENSG00000113448","ENSG00000184588","ENSG00000105650"],"references":[{"source":"PubMed","ids":["24964813","30386231"],"urls":["http://europepmc.org/abstract/MED/24964813","http://europepmc.org/abstract/MED/30386231"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial penicillin-binding protein inhibitor","chemblIds":["CHEMBL1201016"],"targetName":"Bacterial penicillin-binding protein","targetType":"protein family","targets":[],"references":[{"source":"PubMed","ids":["12041787"],"urls":["http://europepmc.org/abstract/MED/12041787"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"PI3-kinase p110-alpha subunit inhibitor","chemblIds":["CHEMBL4650215"],"targetName":"PI3-kinase p110-alpha subunit","targetType":"single protein","targets":["ENSG00000121879"],"references":[{"source":"Other","ids":["https://cancerres.aacrjournals.org/content/77/13_Supplement/156","https://cancerres.aacrjournals.org/content/77/13_Supplement/DDT02-01","https://cancerres.aacrjournals.org/content/78/4_Supplement/PD4-14","https://cancerres.aacrjournals.org/content/80/4_Supplement/OT1-08-04"],"urls":["https://cancerres.aacrjournals.org/content/77/13_Supplement/156","https://cancerres.aacrjournals.org/content/77/13_Supplement/DDT02-01","https://cancerres.aacrjournals.org/content/78/4_Supplement/PD4-14","https://cancerres.aacrjournals.org/content/80/4_Supplement/OT1-08-04"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Matrix metalloproteinase 7 inhibitor","chemblIds":["CHEMBL279785"],"targetName":"Matrix metalloproteinase 7","targetType":"single protein","targets":["ENSG00000137673"],"references":[{"source":"PubMed","ids":["11979428","15975049","9626215","11979428","15975049","9626215","11979428","15975049","9626215","11979428","15975049","9626215","11979428","15975049","9626215","11979428","15975049","9626215"],"urls":["http://europepmc.org/abstract/MED/11979428","http://europepmc.org/abstract/MED/15975049","http://europepmc.org/abstract/MED/9626215","http://europepmc.org/abstract/MED/11979428","http://europepmc.org/abstract/MED/15975049","http://europepmc.org/abstract/MED/9626215","http://europepmc.org/abstract/MED/11979428","http://europepmc.org/abstract/MED/15975049","http://europepmc.org/abstract/MED/9626215","http://europepmc.org/abstract/MED/11979428","http://europepmc.org/abstract/MED/15975049","http://europepmc.org/abstract/MED/9626215","http://europepmc.org/abstract/MED/11979428","http://europepmc.org/abstract/MED/15975049","http://europepmc.org/abstract/MED/9626215","http://europepmc.org/abstract/MED/11979428","http://europepmc.org/abstract/MED/15975049","http://europepmc.org/abstract/MED/9626215"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","chemblIds":["CHEMBL1278146"],"targetName":"Vascular endothelial growth factor receptor 2","targetType":"single protein","targets":["ENSG00000128052"],"references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604"],"urls":["http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604"]},{"source":"PubMed","ids":["24043137","24043137","24043137","24043137","24043137","24043137"],"urls":["http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137"]},{"source":"ClinicalTrials","ids":["NCT02390947","NCT02390947","NCT02390947","NCT02390947","NCT02390947"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT02390947","https://www.clinicaltrials.gov/ct2/show/NCT02390947","https://www.clinicaltrials.gov/ct2/show/NCT02390947","https://www.clinicaltrials.gov/ct2/show/NCT02390947","https://www.clinicaltrials.gov/ct2/show/NCT02390947"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Integrin alpha-4/beta-1 inhibitor","chemblIds":["CHEMBL1201607"],"targetName":"Integrin alpha-4/beta-1","targetType":"protein complex","targets":["ENSG00000150093","ENSG00000115232"],"references":[{"source":"DailyMed","ids":["setid=c5fdde91-1989-4dd2-9129-4f3323ea2962","setid=c5fdde91-1989-4dd2-9129-4f3323ea2962"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5fdde91-1989-4dd2-9129-4f3323ea2962","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5fdde91-1989-4dd2-9129-4f3323ea2962"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatitis C virus serine protease, NS3/NS4A inhibitor","chemblIds":["CHEMBL4297647"],"targetName":"Hepatitis C virus serine protease, NS3/NS4A","targetType":"protein complex","targets":[],"references":[{"source":"Other","ids":["https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.27534","https://www.taiwan-healthcare.org/"],"urls":["https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.27534","https://www.taiwan-healthcare.org/"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Insulin-like growth factor I receptor antagonist","chemblIds":["CHEMBL1743019"],"targetName":"Insulin-like growth factor I receptor","targetType":"single protein","targets":["ENSG00000140443"],"references":[{"source":"PubMed","ids":["15756033"],"urls":["http://europepmc.org/abstract/MED/15756033"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial 70S ribosome inhibitor","chemblIds":["CHEMBL1446","CHEMBL1384"],"targetName":"Bacterial 70S ribosome","targetType":"protein nucleic-acid complex","targets":[],"references":[{"source":"PubMed","ids":["3054810"],"urls":["http://europepmc.org/abstract/MED/3054810"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","chemblIds":["CHEMBL3545285"],"targetName":"Platelet-derived growth factor receptor","targetType":"protein complex","targets":["ENSG00000113721","ENSG00000134853"],"references":[{"source":"PubMed","ids":["21613405","21613405","21613405","21613405","21613405"],"urls":["http://europepmc.org/abstract/MED/21613405","http://europepmc.org/abstract/MED/21613405","http://europepmc.org/abstract/MED/21613405","http://europepmc.org/abstract/MED/21613405","http://europepmc.org/abstract/MED/21613405"]},{"source":"DOI","ids":["10.1016/S1359-6349(04)80149-6","10.1016/S1359-6349(04)80149-6","10.1016/S1359-6349(04)80149-6","10.1016/S1359-6349(04)80149-6","10.1016/S1359-6349(04)80149-6"],"urls":["http://www.sciencedirect.com/science/article/pii/S1359634904801496","http://www.sciencedirect.com/science/article/pii/S1359634904801496","http://www.sciencedirect.com/science/article/pii/S1359634904801496","http://www.sciencedirect.com/science/article/pii/S1359634904801496","http://www.sciencedirect.com/science/article/pii/S1359634904801496"]},{"source":"Other","ids":["http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf","http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf","http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf","http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf","http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf"],"urls":["http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf","http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf","http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf","http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf","http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","chemblIds":["CHEMBL2105712","CHEMBL1173655"],"targetName":"Epidermal growth factor receptor erbB1","targetType":"single protein","targets":["ENSG00000146648"],"references":[{"source":"DailyMed","ids":["fd638e5e-8032-e7ca-0179-95e96ab5d387","fd638e5e-8032-e7ca-0179-95e96ab5d387","fd638e5e-8032-e7ca-0179-95e96ab5d387"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd638e5e-8032-e7ca-0179-95e96ab5d387","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd638e5e-8032-e7ca-0179-95e96ab5d387","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd638e5e-8032-e7ca-0179-95e96ab5d387"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Integrin alpha-4/beta-7 inhibitor","chemblIds":["CHEMBL1743087"],"targetName":"Integrin alpha-4/beta-7","targetType":"protein complex","targets":["ENSG00000115232","ENSG00000139626"],"references":[{"source":"FDA","ids":["label/2014/125476s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125476s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"T-lymphocyte activation antigen CD80 inhibitor","chemblIds":["CHEMBL2109191"],"targetName":"T-lymphocyte activation antigen CD80","targetType":"single protein","targets":["ENSG00000121594"],"references":[{"source":"PubMed","ids":["22267549"],"urls":["http://europepmc.org/abstract/MED/22267549"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL64894","CHEMBL459265"],"references":[{"source":"PubMed","ids":["2272286","3150994"],"urls":["http://europepmc.org/abstract/MED/2272286","http://europepmc.org/abstract/MED/3150994"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Human immunodeficiency virus type 1 reverse transcriptase inhibitor","chemblIds":["CHEMBL4303288","CHEMBL1380"],"targetName":"Human immunodeficiency virus type 1 reverse transcriptase","targetType":"single protein","targets":[],"references":[{"source":"DailyMed","ids":["setid=80c1702a-973c-436a-90f8-69b29674dca0"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80c1702a-973c-436a-90f8-69b29674dca0"]}]}
